Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial
- PMID: 37155240
- PMCID: PMC10203918
- DOI: 10.2196/39700
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial
Abstract
Background: Vaccine safety surveillance is a core component of vaccine pharmacovigilance. In Canada, active, participant-centered vaccine surveillance is available for influenza vaccines and has been used for COVID-19 vaccines.
Objective: The objective of this study is to evaluate the effectiveness and feasibility of using a mobile app for reporting participant-centered seasonal influenza adverse events following immunization (AEFIs) compared to a web-based notification system.
Methods: Participants were randomized to influenza vaccine safety reporting via a mobile app or a web-based notification platform. All participants were invited to complete a user experience survey.
Results: Among the 2408 randomized participants, 1319 (54%) completed their safety survey 1 week after vaccination, with a higher completion rate among the web-based notification platform users (767/1196, 64%) than among mobile app users (552/1212, 45%; P<.001). Ease-of-use ratings were high for the web-based notification platform users (99% strongly agree or agree) and 88.8% of them strongly agreed or agreed that the system made reporting AEFIs easier. Web-based notification platform users supported the statement that a web-based notification-only approach would make it easier for public health professionals to detect vaccine safety signals (91.4%, agreed or strongly agreed).
Conclusions: Participants in this study were significantly more likely to respond to a web-based safety survey rather than within a mobile app. These results suggest that mobile apps present an additional barrier for use compared to the web-based notification-only approach.
Trial registration: ClinicalTrials.gov NCT05794113; https://clinicaltrials.gov/show/NCT05794113.
Keywords: active participant–centered reporting; adverse event reporting; apps; campaign; health technology; immunization; influenza; mobile; mobile apps; pharmacovigilance; safety; surveillance; vaccine.
©A Brianne Bota, Julie A Bettinger, Shirley Sarfo-Mensah, Jimmy Lopez, David P Smith, Katherine M Atkinson, Cameron Bell, Kim Marty, Mohamed Serhan, David T Zhu, Anne E McCarthy, Kumanan Wilson. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 08.05.2023.
Conflict of interest statement
Conflicts of Interest: KW, KA, and CB were cofounders and shareholders of CANImmunize Inc, a corporation that provides consumer facing solutions to immunization information systems. KW has served on the Medicago Independent Data Monitoring Committee and is a member of the Moderna Global Safety Core Consultancy Group. All other authors have no conflicts of interest to disclose.
Figures
References
-
- Cheng AC, Buttery JP. Vaccine safety: what systems are required to ensure public confidence in vaccines? Med J Aust. 2022 Aug 15;217(4):189–190. doi: 10.5694/mja2.51662. https://europepmc.org/abstract/MED/35843626 - DOI - PMC - PubMed
-
- IMPACT after 17 years: Lessons learned about successful networking. Paediatr Child Health. 2009 Jan;14(1):33–39. doi: 10.1093/pch/14.1.33. https://europepmc.org/abstract/MED/19436462 - DOI - PMC - PubMed
-
- Scheifele DW, Halperin SA, CPS/Health Canada‚ Immunization Monitoring Program‚ Active (IMPACT) Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety. Semin Pediatr Infect Dis. 2003 Jul;14(3):213–219. doi: 10.1016/s1045-1870(03)00036-0.S1045187003000360 - DOI - PubMed
-
- Western MJ, Armstrong MEG, Islam I, Morgan K, Jones UF, Kelson MJ. The effectiveness of digital interventions for increasing physical activity in individuals of low socioeconomic status: a systematic review and meta-analysis. Int J Behav Nutr Phys Act. 2021 Nov 09;18(1):148. doi: 10.1186/s12966-021-01218-4. https://ijbnpa.biomedcentral.com/articles/10.1186/s12966-021-01218-4 10.1186/s12966-021-01218-4 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
